Health ❯ Clinical Research

Drug Development

Clinical Trials Preclinical Studies Regulatory Approval Cancer Therapies FDA Approval Monoclonal Antibodies Ezogabine Phase 3 Trials Chimeric Peptides Mechanism of Action Targeted Therapy Nektar Therapeutics Antifungal Research FDA Regulations Anti-inflammatory Medications Patient Trials Regulatory Agencies Antibody Therapy Accelerated Approval Market Competition mRNA Innovations Cancer Drugs Therapeutics Phase Trials Synthetic Biology Personalized Medicine Therapeutic Applications Experimental Treatments Gender Differences Repurposing Drugs

Cholera-Derived Toxin Slows Colorectal Tumors in Mice, Rewiring Local Immunity

Researchers report tumor-targeted activity with safety signals in mouse models using the purified cytotoxin MakA.

Biomea Fusion Prices Equity Offering With Warrants to Raise About $25 Million

FDA Signals Openness to Accelerated Path for Lexeo’s Friedreich’s Ataxia Cardiac Gene Therapy

AI Pinpoints Target of New IBD Antibiotic Enterololin, Speeding Development

Eupraxia Selects 8 mg Dose After Strong EoE Signals, Expands Phase 2b Trial

Liverpool Researchers Report Novltex, a Synthetic Antibiotic Class Against Multidrug-Resistant Bacteria

Novartis to Acquire Tourmaline Bio for $1.4 Billion to Bolster Heart-Drug Pipeline

Terasaki Researchers Debut Human Liver Tumor ‘Embolization-on-a-Chip’ for Embolic Therapy Testing

Autism-Like Behaviors in Mice Traced to Thalamic Circuit as Epilepsy Drug Candidate Reverses Signs

Nektar Therapeutics’ Rezpegaldesleukin Trial Success Sends Shares Up 150%

Acetaminophen Metabolite AM404 Targets Peripheral Nerves to Relieve Pain

UCLA Study Finds Antidepressants Boost Immune Response Against Cancer

New Studies Highlight Ezogabine’s Potential to Redefine Depression Treatment